Raymond Booth

Dr. Raymond Booth

Scientific Founder and Chief Scientist, Seropeutics | Professor, Pharmaceutical Sciences

Seropeutics develops efficacious therapies addressing the needs of Fragile X syndrome, the most common monogenetic form of autism, and has identified two promising candidates, SERx – 519 and SERx – 480 (preclinical development stage).

Ahmed Busnaina

Dr. Ahmed Busnaina

Director, Center for High-rate Nanomanufacturing | Distinguished Professor and Chair, College of Engineering

The Nanoscale Offset Printing System (NanoOps), developed by the Center for High-rate Nanomanufacturing and Milara Inc., represents the ability to print a sweeping array of pharma products of diverse composition with efficient precision.

Shashi Murthy

Dr. Shashi Murthy

Founder, Flaskworks | Professor, College of Engineering

Flaskworks develops modular, closed, and disposable systems for the manufacture of dendritic cells and stimulation and expansion of T cells for the rapidly growing immuno-oncology and dendritic cell-based vaccine markets.

Srinivas Sridhar

Dr. Srinivas Sridhar

Founder, TheraNano | Distinguished Professor, College of Science

TheraNano has a strong pipeline of nanomedicine and medical imaging technologies, including: a platform for sustained delivery of chemotherapeutics; nanoformulations of PARP and other inhibitors for cancer therapy; and, a quantitative MRI method utilizing magnetic nanoparticles to obtain unprecedented vascular images.

Jonathan Tilly

Dr. Jonathan Tilly

Distinguished Professor, College of Science

The Tilly Lab improves women’s reproductive health and overcomes infertility by translating discoveries made through cellular, molecular, genetic, and epigenetic studies of female germ cells. Findings have opened regenerative avenues for overcoming infertility and preventing ovarian failure while also sparking research targeting mitochondria and cellular energy pathways.

Dori Woods

Dr. Dori Woods

Director, Woods Lab | Associate Professor, College of Science

Focusing on female reproduction, the Woods Lab emphasizes new strategies to delay or prevent ovarian failure. Areas of investigation include: the targeted specification of multiple ovarian cell lineages from stem cells; the interaction between ovarian soma and adult ovary germline; the contribution of germline and soma to ovarian failure; and, bioengineering an ‘artificial’ ovary for generating functional eggs from stem cells.